Feliza Mirasol is the science editor for BioPharm International.
Discussing Proper Analysis of HCPs in Biomanufacturing (AAPS PharmSci 360)
October 24th 2024The importance of proper analysis of HCPs in the biomanufacturing process was discussed by Shawn Li, principal scientist at Merck & Co., known as MSD outside the Unites States and Canada, at AAPS PharmSci 360.
The Need for LBFs and Challenges in Oral Biologic Formulation (AAPS PharmSci 360)
October 22nd 2024Karunakar Sukuru, RPh, PhD, the global vice-president-Rx Product Development, Pharma and Consumer Health, at Catalent Pharma Solutions, discussed lipid-based formulations and tackling bioavailability challenges for oral biologics at AAPS PharmSci 360.